CONMED Corp — Director's Dealing 2019

Aug 7, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2019-08-06

Reporting Person: Berge Terence M (VP-Corporate Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-06	Common Stock	M	10000	$32.93	Acquired	29908	Direct
2019-08-06	Common Stock	F	6706	$92.94	Disposed	23202	Direct
2019-08-06	Common Stock	M	6500	$44.90	Acquired	29702	Direct
2019-08-06	Common Stock	F	4786	$92.94	Disposed	24916	Direct
2019-08-06	Common Stock	M	14400	$51.30	Acquired	39316	Direct
2019-08-06	Common Stock	F	11108	$92.94	Disposed	28208	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-06	Sars (Stock Appreciation Rights)	$32.93	M	10000	Disposed	2023-06-01	Common Stock (10000)	Direct
2019-08-06	Sars (Stock Appreciation Rights)	$44.90	M	6500	Disposed	2024-06-01	Common Stock (6500)	Direct
2019-08-06	Sars (Stock Appreciation Rights)	$51.30	M	14400	Disposed	2025-02-27	Common Stock (14400)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period.